Ray Dalio Penumbra Inc Transaction History

Bridgewater Associates, LP

$20.7 Billion
Q1 2025

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Penumbra Inc stock. As of the latest transaction made, Bridgewater Associates, LP holds 1,586 shares of PEN stock, worth $406,697. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,586

Previous 3,990 60.25%

Holding current value

$406,697

Previous $947,000 55.23%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$237.28 - $303.76 $570,421 - $730,239	-2,404 Reduced 60.25%	1,586 $424,000
Q4 2024 Feb 13, 2025	SELL	$190.97 - $253.66 $343,555 - $456,334	-1,799 Reduced 31.08%	3,990 $947,000
Q3 2024 Nov 13, 2024	SELL	$163.64 - $210.12 $2.23 Million - $2.86 Million	-13,613 Reduced 70.16%	5,789 $1.12 Million
Q2 2024 Aug 14, 2024	SELL	$172.27 - $223.95 $165,723 - $215,439	-962 Reduced 4.72%	19,402 $3.49 Million
Q1 2024 May 14, 2024	SELL	$220.09 - $273.15 $4.09 Million - $5.07 Million	-18,577 Reduced 47.71%	20,364 $4.54 Million
Q4 2023 Feb 14, 2024	BUY	$181.44 - $260.22 $3.96 Million - $5.67 Million	21,800 Added 127.18%	38,941 $9.8 Million
Q3 2023 Nov 13, 2023	SELL	$240.69 - $338.77 $5.59 Million - $7.87 Million	-23,241 Reduced 57.55%	17,141 $4.15 Million
Q2 2023 Aug 11, 2023	SELL	$271.54 - $344.06 $1.08 Million - $1.37 Million	-3,993 Reduced 9.0%	40,382 $13.9 Million
Q1 2023 May 12, 2023	SELL	$220.43 - $278.69 $50,037 - $63,262	-227 Reduced 0.51%	44,375 $12.4 Million
Q4 2022 Feb 13, 2023	SELL	$151.88 - $228.5 $2.11 Million - $3.18 Million	-13,909 Reduced 23.77%	44,602 $9.91 Million
Q3 2022 Nov 10, 2022	SELL	$120.36 - $205.88 $69,327 - $118,586	-576 Reduced 0.97%	58,511 $11.1 Million
Q2 2022 Aug 11, 2022	BUY	$116.09 - $227.33 $685,163 - $1.34 Million	5,902 Added 11.1%	59,087 $7.36 Million
Q1 2022 May 13, 2022	BUY	$187.51 - $283.98 $2.72 Million - $4.12 Million	14,524 Added 37.57%	53,185 $11.8 Million
Q4 2021 Feb 14, 2022	BUY	$238.08 - $288.0 $516,633 - $624,960	2,170 Added 5.95%	38,661 $11.1 Million
Q3 2021 Nov 12, 2021	SELL	$250.72 - $291.24 $384,855 - $447,053	-1,535 Reduced 4.04%	36,491 $9.73 Million
Q2 2021 Aug 13, 2021	BUY	$235.0 - $310.7 $3.75 Million - $4.96 Million	15,977 Added 72.46%	38,026 $10.4 Million
Q1 2021 May 14, 2021	BUY	$175.6 - $291.43 $170,507 - $282,978	971 Added 4.61%	22,049 $5.97 Million
Q4 2020 Feb 12, 2021	BUY	$174.98 - $272.83 $2.21 Million - $3.45 Million	12,637 Added 149.71%	21,078 $3.69 Million
Q3 2020 Nov 13, 2020	BUY	$185.27 - $238.73 $1.56 Million - $2.02 Million	8,441 New	8,441 $1.64 Million

Others Institutions Holding PEN

# of Institutions

476

Shares Held

29.1M

Call Options Held

346K

Put Options Held

62.3K

View Full List

About Penumbra Inc

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.72B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

More about PEN

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account